REGENXBIO Inc. (RGNX)
NASDAQ: RGNX · Real-Time Price · USD
8.83
+0.07 (0.80%)
Nov 5, 2024, 11:14 AM EST - Market open
REGENXBIO Analyst Ratings
Total Analysts
11
Consensus Rating
Strong Buy
Price Target
$37.70
Upside
+326.95%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Chardan Capital | Chardan Capital | Strong Buy Maintains $52 | Strong Buy | Maintains | $52 | +488.90% | Oct 22, 2024 |
| Raymond James | Raymond James | Buy Initiates $18 | Buy | Initiates | $18 | +103.85% | Oct 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $39 | Strong Buy | Reiterates | $39 | +341.68% | Sep 4, 2024 |
| Barclays | Barclays | Buy Maintains $55 → $50 | Buy | Maintains | $55 → $50 | +466.25% | Aug 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $38 → $39 | Strong Buy | Maintains | $38 → $39 | +341.68% | Aug 5, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $38 | Strong Buy | Reiterates | $38 | +330.35% | Jun 20, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $38 | Strong Buy | Initiates | $38 | +330.35% | Jun 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $36 → $38 | Strong Buy | Maintains | $36 → $38 | +330.35% | May 15, 2024 |
| Stifel | Stifel | Strong Buy Maintains $40 | Strong Buy | Maintains | $40 | +353.00% | Apr 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $36 | Strong Buy | Initiates | $36 | +307.70% | Mar 11, 2024 |
| RBC Capital | RBC Capital | Hold → Buy Upgrades $20 → $35 | Hold → Buy | Upgrades | $20 → $35 | +296.38% | Mar 8, 2024 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $52 | Strong Buy | Maintains | $52 | +488.90% | Mar 7, 2024 |
| Barclays | Barclays | Buy Maintains $45 → $55 | Buy | Maintains | $45 → $55 | +522.88% | Mar 7, 2024 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades n/a | Hold → Buy | Upgrades | n/a | n/a | Mar 6, 2024 |
| Baird | Baird | Buy Maintains $34 → $39 | Buy | Maintains | $34 → $39 | +341.68% | Mar 6, 2024 |
| Wedbush | Wedbush | Hold Reiterates $21 | Hold | Reiterates | $21 | +137.83% | Feb 28, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.